MOTS-C
Clinician-prescribed. Ships from a licensed U.S. pharmacy.
MOTS-c. A 16-amino acid peptide encoded in the mitochondrial genome that activates AMPK, the master metabolic switch your cells use to regulate energy, insulin sensitivity, and physical capacity. Your mitochondria already produce it. They just produce less of it every year.
The Metabolic Switch Your Mitochondria Lost.
MOTS-c inhibits the folate cycle, causing intracellular AICAR to accumulate. AICAR directly activates AMPK, the enzyme that functions as the cell's master energy sensor. When AMPK fires, the cell shifts to fuel-burning mode: increased glucose uptake via GLUT4, enhanced fatty acid oxidation, new mitochondria built through biogenesis, energy-wasting processes suppressed. This is pharmacological activation of the same pathway that exercise triggers. MOTS-c engages it at the molecular level. Under metabolic stress, MOTS-c goes further: it translocates from the mitochondria to the nucleus, directly regulating gene expression to adapt cellular metabolism to demand.
The Evidence
Conventional Metabolic Interventions vs. MOTS-c (Mitochondrial-Derived Peptide)
| Conventional Metabolic Interventions | MOTS-c (Mitochondrial-Derived Peptide) |
|---|---|
| Metformin activates AMPK but through complex I inhibition with GI side effects | Activates AMPK through endogenous folate-AICAR pathway, no complex I disruption |
| Exercise activates AMPK transiently during activity only | Pharmacological activation of the exercise-mimetic pathway with sustained duration |
| Caloric restriction triggers AMPK but also triggers adaptive metabolic slowdown | No adaptive metabolic resistance; restores the signal, does not create deficit |
| Berberine provides AMPK activation with limited bioavailability and GI issues | Naturally occurring human peptide with favorable tolerability in first-in-human trial |
| NMN/NR address mitochondrial NAD+ without activating the AMPK pathway | Directly addresses mitochondrial signaling alongside metabolic reprogramming |
| Stimulants mask energy deficits without addressing cellular metabolism | Restores cellular energy production capacity rather than overriding symptoms |
Details
- MOTS-c is a 16-amino acid peptide encoded in the mitochondrial genome, discovered in 2015 at USC and published in Cell Metabolism. It was the second mitochondrial-derived peptide ever identified. Its discovery proved mitochondria are not just power plants. They are endocrine organs that regulate metabolism through their own signaling peptides.
- MOTS-c activates AMPK through the folate-AICAR pathway: it inhibits the folate cycle, accumulates AICAR (an endogenous AMP analog), and directly activates the cell's master energy sensor. AMPK triggers increased glucose uptake, fatty acid oxidation, mitochondrial biogenesis, and suppression of energy-consuming anabolic processes. This is the same pathway exercise and caloric restriction activate.
- Under stress, MOTS-c translocates from mitochondria to the nucleus, directly regulating gene expression. It is the first mitochondrial-encoded peptide shown to actively reprogram nuclear transcription.
- Metabolic efficiency improves measurably. Patients report elimination of afternoon energy crashes, improved exercise capacity, and faster recovery. Fasting glucose and insulin sensitivity markers respond within weeks. The metabolic output matches the training input.
- MOTS-c addresses metabolic aging at the mitochondrial level. Age-related decline in MOTS-c production correlates with declining metabolic function, insulin sensitivity, and exercise tolerance. Supplementation restores the signal.
Administer via subcutaneous injection into the abdomen and rotate injection sites with each dose to help minimize skin irritation. Do not inject into areas that are bruised, tender, red, firm, scarred, or otherwise irritated. Follow the dosing instructions provided by your prescribing provider. Do not increase, decrease, skip, or repeat a dose unless directed by your provider. If you miss a dose or have questions, contact your prescribing provider for guidance.
The most common side effects are mild injection site irritation and transient flushing. MOTS-c is a naturally occurring peptide encoded in the human mitochondrial genome, contributing to a favorable tolerability profile. The first-in-human trial (2024) confirmed safety and bioactivity with no significant adverse events reported.
Disclaimer and Transparency
Important Information About Compounded Injectables
- Compounded medications are not reviewed or approved by the FDA and do not undergo the same pre-market evaluation as FDA-approved drugs.
- IVUSE peptide injections are prepared using peptide ingredients by FDA-registered, U.S.-licensed 503A & 503B compounding pharmacies, where available and clinically appropriate.
- Availability and formulation may vary based on state regulations, evolving clinical guidance, and pharmacy partners.
All prescriptions, treatment decisions, and care plans are made independently by licensed healthcare providers using their professional judgment. Images and product depictions are for illustration only; actual packaging and supplies may vary.
*If you are interested in a prescription product, IVUSE will coordinate a telehealth visit with a licensed medical provider who will determine whether you are an appropriate candidate based on your health profile and current standards of care. If approved, a prescription will be issued and filled by one of our partner pharmacies. All prescriptions are subject to provider discretion and clinical appropriateness.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. All information provided here is for educational purposes only and does not replace personalized medical advice from a qualified healthcare professional.
Stop the medication and contact your provider if you experience persistent or concerning symptoms. Seek immediate medical care if you develop signs of a severe allergic reaction (such as hives, facial swelling, or difficulty breathing) or any rapidly worsening symptom.
What happens next
Choose Your Protocol
No consultation fee. No hidden costs. Single vials or a full 12-week cycle.
Complete Your Clinical Intake
A board-certified clinician reviews your health history, medications, and goals. Asynchronous. No appointments. No waiting rooms.
Your Prescription Ships
Compounded by a licensed U.S. pharmacy. Delivered to your door in 2-4 business days. Cold-shipped when required.
Stack Your Protocol
NAD+
Longevity and mitochondrial support during metabolic optimization. NAD+ refuels the coenzyme pool that MOTS-C relies on to drive ATP production.
B12
Energy production and B-vitamin support for exercise mimetic effects. B12 supports red blood cell formation and energy metabolism while MOTS-C optimizes how the mitochondria use it.
SEMAX
Cognitive and neuroprotective benefits alongside metabolic gains. Semax sharpens focus and elevates BDNF while MOTS-C supplies the cellular energy the brain runs on.
